Search Results - "MCGILL, Janet B"

Safety of Sodium-Glucose Co-Transporter 2 Inhibitors by McGill, Janet B., Subramanian, Savitha

“…Sodium-glucose co-transporter 2 (SGLT2) inhibitors have a well-defined safety profile based on data obtained from numerous clinical trials, including…”
Get full text

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY by Garber, Alan J, Handelsman, Yehuda, Grunberger, George, Einhorn, Daniel, Abrahamson, Martin J, Barzilay, Joshua I, Blonde, Lawrence, Bush, Michael A, DeFronzo, Ralph A, Garber, Jeffrey R, Garvey, W Timothy, Hirsch, Irl B, Jellinger, Paul S, McGill, Janet B, Mechanick, Jeffrey I, Perreault, Leigh, Rosenblit, Paul D, Samson, Susan, Umpierrez, Guillermo E

Get more information

Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants by MILLER, Kellee M, BECK, Roy W, BERGENSTAL, Richard M, GOLAND, Robin S, HALLER, Michael J, MCGILL, Janet B, RODRIGUEZ, Henry, SIMMONS, Jill H, HIRSCH, Irl B

“…Despite substantial evidence of the benefit of frequent self-monitoring of blood glucose (SMBG) in type 1 diabetes, certain insurers limit the number of test…”
Get full text

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY by Garber, Alan J, Abrahamson, Martin J, Barzilay, Joshua I, Blonde, Lawrence, Bloomgarden, Zachary T, Bush, Michael A, Dagogo-Jack, Samuel, DeFronzo, Ralph A, Einhorn, Daniel, Fonseca, Vivian A, Garber, Jeffrey R, Garvey, W Timothy, Grunberger, George, Handelsman, Yehuda, Hirsch, Irl B, Jellinger, Paul S, McGill, Janet B, Mechanick, Jeffrey I, Rosenblit, Paul D, Umpierrez, Guillermo E

Get more information

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY by Garber, Alan J, Abrahamson, Martin J, Barzilay, Joshua I, Blonde, Lawrence, Bloomgarden, Zachary T, Bush, Michael A, Dagogo-Jack, Samuel, DeFronzo, Ralph A, Einhorn, Daniel, Fonseca, Vivian A, Garber, Jeffrey R, Garvey, W Timothy, Grunberger, George, Handelsman, Yehuda, Hirsch, Irl B, Jellinger, Paul S, McGill, Janet B, Mechanick, Jeffrey I, Rosenblit, Paul D, Umpierrez, Guillermo E

Get more information

Management of the ‘wicked’ combination of heart failure and chronic kidney disease in the patient with diabetes by Bell, David S. H., McGill, Janet B., Jerkins, Terri

“…Patients with type 2 diabetes are at an increased risk of developing heart failure and chronic kidney disease. The presence of these co‐morbidities…”
Get full text

Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes by Cooper, Mark E., MBBS, PhD, Perkovic, Vlado, MBBS, PhD, McGill, Janet B., MD, Groop, Per-Henrik, MD, DMSC, Wanner, Christoph, MD, Rosenstock, Julio, MD, Hehnke, Uwe, MSc, Woerle, Hans-Juergen, MD, von Eynatten, Maximilian, MD

“…Background Although assessment of cardiovascular safety is mandated by regulatory agencies for the development of new drugs to treat type 2 diabetes,…”
Get full text

Heart failure and diabetes: Clinical significance and epidemiology of this two‐way association by Jerkins, Terri, McGill, Janet B., Bell, David S. H.

“…People with type 2 diabetes (T2DM) and those with prediabetes have an increased risk of heart failure (HF). Longer duration of T2DM correlates with a greater…”
Get full text

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease by Pfeffer, Marc A, Burdmann, Emmanuel A, Chen, Chao-Yin, Cooper, Mark E, de Zeeuw, Dick, Eckardt, Kai-Uwe, Feyzi, Jan M, Ivanovich, Peter, Kewalramani, Reshma, Levey, Andrew S, Lewis, Eldrin F, McGill, Janet B, McMurray, John J.V, Parfrey, Patrick, Parving, Hans-Henrik, Remuzzi, Giuseppe, Singh, Ajay K, Solomon, Scott D, Toto, Robert

“…Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. This…”
Get full text

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review by McGill, Janet B.

“…Introduction The treatment of type 2 diabetes mellitus (T2DM) continues to pose challenges for clinicians and patients. The dramatic rise in T2DM prevalence,…”
Get full text

Clinical Implications of Estimated Glomerular Filtration Rate Dip Following Sodium-Glucose Cotransporter-2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes by Xie, Yan, Bowe, Benjamin, Gibson, Andrew K, McGill, Janet B, Maddukuri, Geetha, Al-Aly, Ziyad

“…Background The frequency of the initial short-term decline in estimated glomerular filtration rate (eGFR), eGFR dip, following initiation of sodium-glucose…”
Get full text

Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease by Hughes, Jing W, Bao, Yicheng K, Salam, Maamoun, Joshi, Prajesh, Kilpatrick, C Rachel, Juneja, Kavita, Nieves, David, Bouhairie, Victoria, Jordan, Olivia J, Blustein, Erica C, Tobin, Garry S, McGill, Janet B

“…Type 1 diabetes (T1DM) is associated with other autoimmune diseases (AIDs), which may have serious health consequences. The epidemiology of AIDs in T1DM is not…”
Get full text

Decreased sarcoplasmic reticulum phospholipids in human skeletal muscle are associated with metabolic syndrome by Adamson, Samantha E., Adak, Sangeeta, Petersen, Max C., Higgins, Dustin, Spears, Larry D., Zhang, Rong Mei, Cedeno, Andrea, McKee, Alexis, Kumar, Aswathi, Singh, Sudhir, Hsu, Fong-Fu, McGill, Janet B., Semenkovich, Clay F.

“…Metabolic syndrome affects more than one in three adults and is associated with increased risk of diabetes, cardiovascular disease, and all-cause mortality…”
Get full text

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary by Garber, Alan J, Abrahamson, Martin J, Barzilay, Joshua I, Blonde, Lawrence, Bloomgarden, Zachary T, Bush, Michael A, Dagogo-Jack, Samuel, Davidson, Michael B, Einhorn, Daniel, Garvey, W Timothy, Grunberger, George, Handelsman, Yehuda, Hirsch, Irl B, Jellinger, Paul S, McGill, Janet B, Mechanick, Jeffrey I, Rosenblit, Paul D, Umpierrez, Guillermo E, Davidson, Michael H

Get more information

Weight-Bearing Versus Nonweight-Bearing Exercise for Persons With Diabetes and Peripheral Neuropathy: A Randomized Controlled Trial by Mueller, Michael J., PT, PhD, Tuttle, Lori J., PT, PhD, LeMaster, Joseph W., MD, MPH, Strube, Michael J., PhD, McGill, Janet B., MD, MA, Hastings, Mary K., PT, DPT, ATC, Sinacore, David R., PT, PhD

“…Abstract Objective To determine the effects of weight-bearing (WB) versus nonweight-bearing (NWB) exercise for persons with diabetes mellitus (DM) and…”
Get full text

Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes by Tuttle, Katherine R, Bakris, George L, Toto, Robert D, McGill, Janet B, Hu, Kuolung, Anderson, Pamela W

“…OBJECTIVE:--Ruboxistaurin selectively inhibits protein kinase C-{szligbeta} and ameliorates kidney disease in animal models of diabetes. The purpose of this…”
Get full text

Short-term multifactorial intervention (STEMI): An approach using structured blood glucose monitoring (BGM) and conventional therapies in persons with diabetes by Zelada, Henry, Recklein, Carol L., McGill, Janet B.

“…A BSTRACT Background: Achieving glucose and glycosylated hemoglobin (HbA1c) targets have been shown to reduce long-term microvascular complications of…”
Get full text

Sex and Type 2 Diabetes: Obesity-Independent Effects on Left Ventricular Substrate Metabolism and Relaxation in Humans by Peterson, Linda R., Saeed, Ibrahim M., McGill, Janet B., Herrero, Pilar, Schechtman, Kenneth B., Gunawardena, Ratnasiri, Recklein, Carol L., Coggan, Andrew R., DeMoss, Amanda J., Dence, Carmen S., Gropler, Robert J.

“…Patients with type 2 diabetes (T2DM), particularly women, are at risk for heart failure. Myocardial substrate metabolism derangements contribute to cardiac…”
Get full text

Effect of Ruboxistaurin on Albuminuria and Estimated GFR in People With Diabetic Peripheral Neuropathy: Results From a Randomized Trial by Tuttle, Katherine R., MD, McGill, Janet B., MD, Bastyr, Edward J., MD, Poi, Keri Kles, PhD, Shahri, Nazila, MSc, Anderson, Pamela W., MD

Get full text

Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials by McGill, Janet B.

“…Patients with type 2 diabetes mellitus (T2DM) frequently require multiple therapies to effectively control hyperglycemia, and many new agents for glucose…”
Get full text